Back to results
US 12,583,862 B2Granted
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
AssigneeNurix Therapeutics, Inc.
InventorsDaniel W. Robbins, Arthur T. Sands, Joel Mcintosh, Jeffrey Mihalic, Jeffrey Wu, Daisuke Kato, Dahlia Weiss, Ge Peng
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Claims19
A compound of Formula (X):
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is C1-3 alkyl;
- ring A is phenyl, 5-6 membered partially or fully unsaturated monocyclic heterocycle, 9-10 membered bicyclic aryl, or 9-10 membered bicyclic heteroaryl, wherein the heterocycle and the bicyclic heteroaryl of ring A each independently have 1-3 heteroatoms independently selected from N, O, or S;
- L is —X1—X2—X3—X4—X5—;
- X1 is —C(O)—N(R)—, —N(R)—C(O)—, —(O—CH2—CH2)m—, —O(C6H4)—, —(O—CH2—CH2—CH2)m—, —C1-5 alkyl-, 7-12 membered spiro bicyclic heterocycloalkyl having 1-3 heteroatoms independently selected from N, O, or S wherein the bicyclic heterocycloalkyl of X1 is optionally substituted with —CH3, or 4-6 membered monocyclic heterocycloalkyl having 1-2 heteroatoms independently selected from N, O, or S wherein the monocyclic heterocycloalkyl of X1 is optionally substituted with —CH3;
- X2 is a bond, —(O—CH2—CH2)n—, —(CH2—CH2—O)n—, —N(R)—C(O)—, —N(R)—, —C(O)—, —C1-5 alkyl-, 4-6 membered monocyclic cycloalkyl, or 4-6 membered monocyclic heterocycloalkyl having 1-2 heteroatoms independently selected from N, O, or S;
- X3 is a bond, —C1-4 alkyl-, —C≡C—, 4-6 membered cycloalkyl, —N(R)—, —(O—CH2—CH2)p—, —(CH2—CH2—O)p—, 4-6 membered heterocycloalkyl having 1-2 heteroatoms independently selected from N, O, or S wherein the heterocycloalkyl is optionally substituted with —CH3 or —N(R)—;
- X4 is a bond, —CH2—CH2—N(R)—, —N(R)—, —C1-4alkyl-, —(O—CH2—CH2—CH2)m—, a 5-6 membered saturated, partially unsaturated, or fully unsaturated carbocycle, or a 5-6 membered saturated, partially unsaturated, or fully unsaturated heterocycle having 1-3 heteroatoms independently selected from N, O, or S;
- X5 is a bond, —C1-4 alkyl-, —N(R)—, or —C(O)—N(R)—;
- each R is independently —H or —C1-3 alkyl;
- each of m, n, and p is independently an integer from 1 to 3;
- and
- Y is
- wherein:
- each R2 is independently halo or C1-4 alkyl;
- each Z is —C(RA)2— or —C(O)—;
- each RA is independently —H or C1-4 alkyl;
- and
- q is 0, 1, or 2.
16 more elements
Dependencies are inferred from the claim text.